Analyst consensus rating
Fortress Biotech Analyst Rating: none
FBIO is rated none by 2 analysts with a $11.00 target. As of 2026-08-22.
Direct answer
Fortress Biotech's consensus rating is none.
2 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $11.00.
Forecast evidence checked August 22, 2026.
Get free Fortress Biotech email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $2.87
- Average price target
- $11.00
- High price target
- $17.00
- Low price target
- $5.00
- Low target gap
- +74.2%
- Target upside
- +283.3%
- High target gap
- +492.3%
- Target range width
- 418.1%
- Consensus rating
- none
- Analysts
- 2
- Evidence date
- August 22, 2026
- Valid through
- August 29, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Fortress Biotech?
Fortress Biotech has a verified none consensus. The same dataset has an average price target of $11.00.
How far are Fortress Biotech's low and high targets from the recorded price?
The low target implies +74.2%, while the high target implies +492.3%.
How many analysts are included in Fortress Biotech's consensus?
The verified consensus includes 2 analysts.
How is Fortress Biotech's target upside or downside calculated?
The average target of $11.00 is divided by the recorded price of $2.87, then one is subtracted to produce +283.3%. This does not guarantee a future return.
When was Fortress Biotech's analyst forecast verified?
The data was verified on 2026-08-22. The dataset is valid through 2026-08-29.